The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 04, 2018

Filed:

Jan. 14, 2015
Applicants:

Shin Nippon Biomedical Laboratories, Ltd., Kagoshima-shi, JP;

Wave Life Sciences Japan, Inc., Kagoshima-shi, JP;

Inventors:

Takefumi Gemba, Kagoshima, JP;

Ryoichi Nagata, Kagoshima, JP;

Ikumi Shiga, Kagoshima, JP;

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 15/117 (2010.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); A61K 31/7088 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/117 (2013.01); A61K 31/7088 (2013.01); A61K 39/39 (2013.01); A61K 48/00 (2013.01); A61K 2039/55561 (2013.01); C12N 2310/17 (2013.01); C12N 2310/315 (2013.01); C12N 2310/344 (2013.01); C12N 2320/30 (2013.01);
Abstract

Problem The purpose of the present invention is to provide: a chiral nucleic acid adjuvant having immunity-inducing activity and an immunity-inducing activator. Solution The present invention relates to an adjuvant which comprises oligonucleotides which comprise two to four sequences each represented by 5'-XCpG X-3′ and has a length of 14 to 32 nucleotides, wherein a nucleic acid at 3′ end side of at least two CpG motifs is connected by phosphorothioate linkage, wherein each nucleic acids at 3′ end and 5′ end of the oligonucleotide is S type nucleic acids connected by phosphorothioate linkage, and wherein the oligonucleotide comprises at least one nucleic acid without phosphorothioate modification. The present invention relates to an immunity-inducible activator comprising the adjuvant.


Find Patent Forward Citations

Loading…